Skip to main content
. 2022 Sep 8;13:900273. doi: 10.3389/fimmu.2022.900273

Figure 10.

Figure 10

The mechanism that the low expression of IL-17B means a better immunotherapeutic response in BLCA. (created with biorender.com).